Literature DB >> 12812884

Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy.

D E Goldberg1, H Wang, S P Azen, W R Freeman.   

Abstract

BACKGROUND: Healed cytomegalovirus (CMV) retinitis in the setting of highly active antiretroviral therapy (HAART) is complicated by inflammatory sequelae and vision loss. AIM: To determine the long term visual outcome of AIDS patients with CMV retinitis who received HAART.
METHODS: 90 eyes of 63 consecutive AIDS patients with extramacular CMV retinitis were studied prospectively.
RESULTS: Immune recovery status was related to time to onset of epiretinal membrane (p=0.05) and cystoid macular oedema (p=0.06) as well as to the incidence of cataract (p=0.001) and moderate vision loss (p<0.0001). Severe vision loss was associated with retinal detachment (p<0.001).
CONCLUSION: AIDS patients with extramacular CMV retinitis lose vision while on HAART. HAART related immune recovery is associated with increased frequencies of epiretinal membrane, cystoid macular oedema, cataract, and retinal detachment with resultant vision loss in AIDS patients with healed CMV retinitis.

Entities:  

Mesh:

Year:  2003        PMID: 12812884      PMCID: PMC1771778          DOI: 10.1136/bjo.87.7.853

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  Immune recovery uveitis.

Authors:  G N Holland
Journal:  Ocul Immunol Inflamm       Date:  1999-12       Impact factor: 3.070

2.  Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis.

Authors:  W R Freeman; D E Henderly; W L Wan; D Causey; M Trousdale; R L Green; N A Rao
Journal:  Am J Ophthalmol       Date:  1987-04-15       Impact factor: 5.258

3.  Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.

Authors:  S M Mitchell; W L Membrey; M S Youle; A Obi; S Worrell; B G Gazzard
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

4.  Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.

Authors:  B E Silverstein; J H Smith; S O Sykes; M R Jones; D Schwartz; E T Cunningham
Journal:  Am J Ophthalmol       Date:  1998-03       Impact factor: 5.258

5.  Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.

Authors:  Q D Nguyen; J H Kempen; S G Bolton; J P Dunn; D A Jabs
Journal:  Am J Ophthalmol       Date:  2000-05       Impact factor: 5.258

6.  Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.

Authors:  J C Macdonald; M P Karavellas; F J Torriani; L S Morse; I L Smith; J B Reed; W R Freeman
Journal:  Ophthalmology       Date:  2000-05       Impact factor: 12.079

7.  Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.

Authors:  Mi-Kyoung Song; Stanley P Azen; Ann Buley; Francesca Torriani; Lingyun Cheng; Sunan Chaidhawangul; Ugur Ozerdem; Barbara Scholz; William R Freeman
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

8.  Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.

Authors:  W R Freeman; D N Friedberg; C Berry; J I Quiceno; M Behette; S C Fullerton; D Munguia
Journal:  Am J Ophthalmol       Date:  1993-12-15       Impact factor: 5.258

9.  Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.

Authors:  M P Karavellas; D J Plummer; J C Macdonald; F J Torriani; C L Shufelt; S P Azen; W R Freeman
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

  9 in total
  9 in total

1.  Cytomegaloviral retinitis-related retinal detachment: outcomes following vitrectomy in the developing world.

Authors:  Sri K Gore; Daniel M Gore; Kreasen Chetty; Linda Visser
Journal:  Int Ophthalmol       Date:  2013-06-21       Impact factor: 2.031

2.  Challenging treatment of bilateral multiple infection panuveitis in HIV/AIDS patients.

Authors:  Widya Artini; Soedarman Sjamsoe; Made Susiyanti
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

3.  The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Authors:  Igor Kozak; Vijay Vaidya; Mark L Van Natta; Jeong W Pak; K Patrick May; Jennifer E Thorne
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-12       Impact factor: 4.799

4.  Cytomegalovirus retinitis in the post-cART era.

Authors:  Alexander D Port; Rolake O Alabi; Lisa Koenig; Mrinali P Gupta
Journal:  Curr Ophthalmol Rep       Date:  2018-05-02

5.  Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in Shanghai, China.

Authors:  Ying Shi; Hongzhou Lu; Taiwen He; Yalin Yang; Li Liu; Renfang Zhang; Yufang Zheng; Yinzhong Shen; Yunzhi Zhang; Zhiyong Zhang
Journal:  BMC Infect Dis       Date:  2011-11-24       Impact factor: 3.090

6.  Think Out of the Box, Think Out of the Eye Reappraisal of HIV/AIDS Retinopathy.

Authors:  Francesco Pichi; Paolo Romani; Paola Carrai; Paolo Nucci
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

7.  Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore.

Authors:  Tun Hang Yeo; Tun Kuan Yeo; Elizabeth P Wong; Rupesh Agrawal; Stephen C Teoh
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-11-07

8.  Immune recovery uveitis masked as an endogenous endophthalmitis in a patient with active CMV retinitis.

Authors:  Ligia Figueiredo; Renata Rothwell; Miguel Bilhoto; Rosário Varandas; Sofia Fonseca
Journal:  Case Rep Ophthalmol Med       Date:  2013-04-09

9.  Outcome of surgery in post-cytomegalovirus retinal detachment: experience before and in the era of highly active anti-retroviral therapy in Indian eyes.

Authors:  Ramandeep Singh; Swapnil Bhalekar; Swapnil Parchand; Aman Sharma; Vishali Gupta; Mangat R Dogra; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2013-11       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.